"Anticonvulsants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent SEIZURES or reduce their severity.
| Descriptor ID |
D000927
|
| MeSH Number(s) |
D27.505.954.427.080
|
| Concept/Terms |
Anticonvulsants- Anticonvulsants
- Anticonvulsive Agents
- Agents, Anticonvulsive
- Anticonvulsive Drugs
- Drugs, Anticonvulsive
- Anticonvulsant Drugs
- Drugs, Anticonvulsant
Antiepileptic Agents- Antiepileptic Agents
- Agents, Antiepileptic
- Antiepileptics
- Antiepileptic Drugs
- Drugs, Antiepileptic
|
Below are MeSH descriptors whose meaning is more general than "Anticonvulsants".
Below are MeSH descriptors whose meaning is more specific than "Anticonvulsants".
This graph shows the total number of publications written about "Anticonvulsants" by people in this website by year, and whether "Anticonvulsants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 1 | 5 |
| 1996 | 4 | 2 | 6 |
| 1997 | 2 | 0 | 2 |
| 1998 | 3 | 4 | 7 |
| 1999 | 9 | 3 | 12 |
| 2000 | 5 | 3 | 8 |
| 2001 | 4 | 2 | 6 |
| 2002 | 8 | 0 | 8 |
| 2003 | 14 | 5 | 19 |
| 2004 | 7 | 4 | 11 |
| 2005 | 9 | 2 | 11 |
| 2006 | 10 | 4 | 14 |
| 2007 | 5 | 4 | 9 |
| 2008 | 7 | 3 | 10 |
| 2009 | 9 | 5 | 14 |
| 2010 | 6 | 6 | 12 |
| 2011 | 6 | 5 | 11 |
| 2012 | 6 | 1 | 7 |
| 2013 | 7 | 8 | 15 |
| 2014 | 4 | 3 | 7 |
| 2015 | 12 | 6 | 18 |
| 2016 | 7 | 4 | 11 |
| 2017 | 8 | 1 | 9 |
| 2018 | 11 | 3 | 14 |
| 2019 | 5 | 1 | 6 |
| 2020 | 4 | 3 | 7 |
| 2021 | 5 | 6 | 11 |
| 2022 | 2 | 4 | 6 |
| 2023 | 1 | 5 | 6 |
| 2024 | 8 | 3 | 11 |
| 2025 | 4 | 3 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticonvulsants" by people in Profiles.
-
WONOEP XVII appraisal: Targeting network excitability beyond the synapse -Neurotransmitter, ionic, and electro -diffusions. Epilepsia. 2025 Nov; 66(11):4139-4161.
-
Seizure monitoring by combined diary and wearable data: A multicenter, longitudinal, observational study. Epilepsia. 2025 Nov; 66(11):4259-4271.
-
Brivaracetam effectiveness and patient-reported outcomes in clinical practice: Data from a 12-month prospective, observational study in the United States. Epilepsy Behav. 2025 Dec; 173:110565.
-
Time to treatment in pediatric patients with repeated episodes of status epilepticus. BMC Neurol. 2025 May 26; 25(1):221.
-
Prescribing errors in hospitalized patients on the ketogenic diet. Am J Health Syst Pharm. 2025 May 23; 82(Supplement_3):S2937-S2942.
-
Factors influencing seizure induction in patients with intracranial EEG recording. Epilepsia. 2025 Jun; 66(6):2089-2098.
-
Ethosuximide-associated Aplastic Anemia Likely Due to Drug-induced Lupus Erythematosus: A Case Report With Immunologic Insights. J Pediatr Hematol Oncol. 2025 Apr 01; 47(3):131-134.
-
An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome. HGG Adv. 2025 Apr 10; 6(2):100393.
-
WONOEP appraisal: Targeted therapy development for early onset epilepsies. Epilepsia. 2025 Feb; 66(2):328-340.
-
Lack of association of first and second-line medication dosing and progression to refractory status epilepticus in children. Seizure. 2024 Dec; 123:133-141.